Evidence map›Paper›PMID 38559753›Full record

ArticleVaccine: X2024

Enablers and barriers to rotavirus vaccine coverage in Assam, India- A qualitative study.

Rashmi Mehra, Arindam Ray, Sabita Das, Biman Kusum Chowdhury, Seema Singh Koshal, Rhythm Hora, Amrita Kumari, Amanjot Kaur, Syed F Quadri, Arup Deb Roy

Open access · goldAbstract read
In one paragraph

Article in Vaccine: X, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Rashmi MehraJohn Snow India, New Delhi, India.
Arindam RayBill and Melinda Gates Foundation, New Delhi, India.
Sabita DasGovernment of Assam, Guwahati, India.
Biman Kusum ChowdhuryGovernment of Assam, Guwahati, India.
Seema Singh KoshalJohn Snow India, New Delhi, India.
Rhythm HoraJohn Snow India, New Delhi, India.
Amrita KumariJohn Snow India, New Delhi, India.
Amanjot KaurJohn Snow India, New Delhi, India.
Syed F QuadriJohn Snow India, New Delhi, India.
Arup Deb RoyJohn Snow India, New Delhi, India.
Gates Foundation · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Estimates suggest that 78,000 children died due to rotavirus gastroenteritis annually between 2011 and 2013 in India. The north eastern state of Assam reported 38.4% pediatric diarrheal admissions testing positive for rotavirus. Rotavirus vaccine (RVV) was introduced in Assam in 2017 following which the National Family Health Survey-5 (NFHS-5) (2019) revealed low RVV coverage in Assam with wide variation between the districts. the current study was conceptualized and undertaken to capture the enablers and barriers to RVV coverage in Assam. Methods: Qualitative study conducted in 5 randomly selected districts in Assam. Participants (key informants) were recruited by purposive sampling at each level of the health system including healthcare officials, service providers and caregivers based on availability. Thirty-five in-depth interviews (IDIs) and five focus group discussions (FGDs) were conducted. Interviews were tape recorded and transcribed. Data was coded and analyzed using the thematic framework approach. Results: Findings from the qualitative data collection were collated and analyzed under 7 identified themes. Difficult terrain, limited service provider availability and no catch-up training for new recruits were some of the barriers to RVV coverage. In contrast, Information, Education & Communication (IEC) in vernacular language, RVV safety profile, development partner support and adequate RVV supply were identified as some of the enablers of RVV coverage. Conclusion: Few broad recommendations to overcome identified barriers include comprehensive inter-sectoral coordination, regular monitoring and frequent refresher training sessions. There is a need for a future study utilizing existing coverage data and larger sample size to triangulate the findings of this study.

Indexed as

CoverageHealthcareIndiaRotavirus vaccineUniversal Immunization ProgrammeVaccine

Identifiers

PMID38559753
PMCPMC10979257
OpenAlexW4392946542

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.